National Eye Institute Biorepository for Retinal Diseases

Plain-language summary

This is a biorepository (sample bank) collecting blood and tissue to study retinal diseases. It enrolls people with diagnosed or undiagnosed retinal disease (especially age-related macular degeneration and diabetic retinopathy) and healthy controls. It is an observational (non-phase) study and is currently recruiting.

The summary above is a plain-language rendering of the official record. The original English title is shown for reference.

Trial details

Phase

N/A

Status

Recruiting

Sponsor

National Eye Institute (NEI)

Start date

6/18/2012

Countries

United States

Related genes

Locations

• Bethesda, United States

Eligibility criteria

Criteria are reproduced from the ClinicalTrials.gov record in the original English. Only the trial team can determine eligibility.

* INCLUSION CRITERIA:

Participants will be eligible if they:

* Have the ability to understand and sign an informed consent or have a parent/legal guardian to do so if they are minor children.
* Manifest diagnosed or undiagnosed retinal disease(s), or could serve as an unaffected control suitable for comparison to participants with various retinal diseases, particularly AMD and diabetic retinopathy (taking into account matching factors such as age and past ocular history).

EXCLUSION CRITERIA:

Participants will not be eligible if they:

* Are unable or unwilling to give informed consent that includes collection and study of at least one peripheral blood sample.
* Are unable or unwilling to give informed consent that includes use of NIH medical records and clinical samples for research.
* Have a systemic disease that compromises the ability to provide adequate ophthalmologic examination or treatment.